REFERENCES
- Aboueid, S., R. H. Liu, B. N. Desta, A. Chaurasia, and S. Ebrahim. 2019. The use of artificially intelligent self-diagnosing digital platforms by the general public: Scoping review. JMIR Medical Informatics 7(2): e13445. doi: https://doi.org/10.2196/13445.
- Cohen, B. S., J. Denvil, F. A. Raso, and S. Degroff. 2021. FTC authority to regulate artificial intelligence. Reuters. https://www.reuters.com/legal/legalindustry/ftc-authority-regulate-artificial-intelligence-2021-07-08/.
- Grand View Research. 2022. Mental health apps market size, share & trends analysis report by platform type (Android, iOS), by application type (depression and anxiety management, stress management), By Region, And Segment Forecasts, 2022–2030. Accessed March 28, 2022. https://www.grandviewresearch.com/industry-analysis/mental-health-apps-market-report.
- Ho, A., and O. Quick. 2018. Leaving patients to their own devices? Smart technology, safety and therapeutic relationships. BMC Med Ethics 19(1): 18. doi: https://doi.org/10.1186/s12910-018-0255-8.
- Skorburg, J. A., and J. Yam. 2022. Is there an App for that?: Ethical issues in the digital mental health response to COVID-19. AJOB Neuroscience 13(3): 177–190. doi:https://doi.org/10.1080/21507740.2021.1918284.
- Taquet, M., J. R. Geddes, M. Husain, S. Luciano, and P. J. Harrison. 2021. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. The Lancet. Psychiatry 8(5): 416–27. doi: https://doi.org/10.1016/S2215-0366(21)00084-5.
- Tekin, Ş. 2021. Is big data the new stethoscope? Perils of digital phenotyping to address mental illness. Philosophy & Technology 34(3): 447–61. doi: https://doi.org/10.1007/s13347-020-00395-7.
- U.S. Food and Drug Administration (FDA). 2019a. Examples of software functions for which the FDA will exercise enforcement discretion. Accessed January 5, 2022. https://www.fda.gov/medical-devices/device-software-functions-including-mobile-medical-applications/examples-software-functions-which-fda-will-exercise-enforcement-discretion.
- U.S. Food and Drug Administration (FDA). 2019b. Policy for device software functions and mobile medical applications: Guidance for industry and food and drug administration staff. Accessed January 5, 2022. https://www.fda.gov/media/80958/download.
- Wagner, J. K. 2020. The federal trade commission and consumer protections for mobile health apps. The Journal of Law, Medicine & Ethics 48(1_suppl): 103–14. doi: https://doi.org/10.1177/1073110520917035.
- World Health Organization. 2022. Mental health and COVID-19: Early evidence of the pandemic’s impact: Scientific brief. Accessed April 20, 2022. https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Mental_health-2022.1.